Mice vaccinated with irradiated B16 melanoma cells and treated with checkpoint signal blockade including anti-CTLA-4 and/or anti-PD-1resulted in marked resolution of solid tumor burden and increased CD4+/CD8+ to Treg ratio in the tumor (75). This evidence concerns the gene CD8A and neoplasm.